VirxSys Lentivirus IND For HIV Will Be Filed By First Quarter of 2002
Executive Summary
VirxSys is planning to submit an investigational new drug application for its HIV-1 lentiviral vector for treatment of patients infected with HIV by the first quarter of 2002